Esperion Therapeutics
ESPR
#6169
Rank
ยฃ0.66 B
Marketcap
ยฃ2.80
Share price
-1.58%
Change (1 day)
6.96%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of September 2025 : -ยฃ0.34 Billion

According to Esperion Therapeutics's latest financial reports the company has -ยฃ0.34 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-ยฃ0.31 Billion-13.27%
2023-12-31$-ยฃ0.36 Billion33.44%
2022-12-31$-ยฃ0.27 Billion83.43%
2021-12-31$-ยฃ0.15 Billion106.87%
2020-12-31$-ยฃ70.53 Million-563.58%
2019-12-31$ยฃ15.21 M-75.59%
2018-12-31$ยฃ62.32 M-65.57%
2017-12-31$ยฃ0.18 B-2.28%
2016-12-31$ยฃ0.18 B-4.42%
2015-12-31$ยฃ0.19 B125.97%
2014-12-31$ยฃ85.78 M90.98%
2013-12-31$ยฃ44.91 M-517.48%
2012-12-31$-ยฃ10.76 Million176.1%
2011-12-31$-ยฃ3.9 Million
2002-12-31$ยฃ24.16 M-47.32%
2001-12-31$ยฃ45.86 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ12.12 M-103.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.54 B-1,441.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ69.88 B-20,725.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ23.23 B-6,958.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.17 B-151.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
ยฃ90.19 M-126.62%๐Ÿ‡บ๐Ÿ‡ธ USA